Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, BFA

Vitalacy Launches AI Virtual Care Solution for Enhanced Patient Safety and Remote Monitoring


LOS ANGELES, Feb. 6, 2025 /PRNewswire/ -- Vitalacy, Inc., a leader in patient safety technology, is proud to announce the launch of its AI-driven Virtual Care solution, designed to enhance patient safety, reduce hospital falls, and optimize hospital efficiency through 24/7 AI-powered remote monitoring.

Vitalacy's Virtual Care system employs advanced artificial intelligence to continuously monitor patients in bed, providing real-time alerts to prevent unattended bed exits and reduce the risk of patient falls and elopements. With its two-way communication capabilities, the solution enables healthcare staff to intervene promptly, ensuring higher levels of patient care while alleviating workload pressures on nurses and caregivers.

What sets Vitalacy's Virtual Care solution apart from other offerings on the market is its ability to identify potential risks more effectively than traditional solutions like bed alarms or telesitters. Its integration of stereo cameras, advanced AI learning, and automated patient bed detection capabilities allow for highly accurate monitoring, reducing false alarms and ensuring timely interventions. The stereo cameras provide precise depth perception, while the AI-driven learning continuously adapts to patient behavior.

"The launch of our Virtual Care solution marks a significant milestone in our patient safety offerings," said Janel Raanan, CEO and Co-founder of Vitalacy. "By leveraging AI-driven alerts and real-time remote monitoring, we are empowering healthcare providers with the tools they need to prevent falls and improve efficiency. In addition, Vitalacy Virtual Care pairs well with our existing hand hygiene monitoring solutions to reduce harm in hospitals and enhance the overall patient experience."

"Vitalacy's Virtual Care platform is a game-changer for the healthcare industry," said Bahram Nour-Omid, Co-founder and President of the Board at Vitalacy. "This technology provides healthcare teams with the crucial support they need, ensuring patient safety while enhancing staff productivity. We are confident that this solution will have a meaningful impact on patient care and hospital operations, further strengthening Vitalacy as a leader in patient safety technologies."

Vitalacy's Virtual Care solution is now available for healthcare institutions looking to modernize their patient safety protocols. For more information, visit www.vitalacy.ai.

About Vitalacy Vitalacy is a leading provider of healthcare technology solutions dedicated to improving patient safety, staff efficiency, and operational outcomes. Through AI-powered innovations, Vitalacy delivers tools that help healthcare providers enhance the quality of care and reduce preventable incidents.

SOURCE Vitalacy


These press releases may also interest you

at 04:05
Sofinnova Partners ("Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, today announced the final close of Sofinnova Biovelocita II. The fund has exceeded its target, successfully raising ?165M, with...

at 04:00
Taiwan-based Formosa Pharmaceuticals (6838.TW) today announced an exclusive licensing agreement with Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as "Cipla" for the commercialization of clobetasol propionate ophthalmic suspension, 0.05%...

at 03:23
Oncorena is pleased to announce that the FDA has approved the Company's IND application to initiate the Phase I/II study Oncorella-1: A Phase 1/2, open label, single arm study on safety, tolerability and anti-tumor efficacy of orellanine treatment in...

at 03:00
Medit (www.medit.com), a global leader in digital dentistry, has launched its latest All-on-X solution, Medit SmartX. This innovative solution empowers implant clinicians to fully leverage the potential of the digital ecosystem. Medit SmartX...

at 02:05
Protembis, a privately-held emerging cardiovascular medical device company, announced today the establishment of a Scientific Advisory Board (SAB) to provide objective advice and contribute to the strategic plans of the company. Specifically, the SAB...

at 02:04
Consumers searching for PrimeBiome gummies, a product developed under Bioventra, may have encountered limited availability in recent weeks as demand continues to outpace supply. The rising popularity of PrimeBiome has led to unprecedented stock...



News published on and distributed by: